Blinatumomab satellite symposium

13.00–14.00, Monday, 4 May 2020
Auditorium 2

A debate on the outcome-transforming potential of T-cell engaging immuno-oncology therapy in paediatric ALL:
the BiTE® blinatumomab vs CAR-T cells 


Speaker Topic
Peter Bader (Germany) The role of CAR-T cells
Franco Locatelli (Italy) The role of blinatumomab, a bispecific T-cell engager (BiTE®)
All Panel discussion
CAUTION: Please be aware of fraudulent third party websites that attempt to mislead event participants by offering Accommodation and Registration services. They may claim to be part of the 'official SIOP Europe Annual Meeting'. Please note that the SIOP Europe has no agreement or affiliation with these providers and we recommend that delegates/companies do not give information to them.